EYLEA HD FDA approval date
The FDA approved EYLEA HD on 18 Aug 2023.
- FDA approval date
- 18 Aug 2023
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as AFLIBERCEPT
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2023-08-18Day | EYLEA HD | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA761355", "applicant_as_listed_by_fda": "REGENERON PHARMACEUTICALS", "brand_names": ["EYLEA HD"], "active_ingredients": ["AFLIBERCEPT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230818", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |